[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![IncredibleTrade Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::47247213.png) IT [@IncredibleTrade](/creator/twitter/IncredibleTrade) on x 46.6K followers
Created: 2025-06-15 02:14:25 UTC

$CLDX Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase X Study in Chronic Spontaneous Urticaria at EAACI 2025 
XX% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were angioedema free at Week XX
Data further support barzolvolimab clinical benefit to patients with CSU


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1934071970565390836/c:line.svg)

**Related Topics**
[$mngl](/topic/$mngl)
[$cldx](/topic/$cldx)

[Post Link](https://x.com/IncredibleTrade/status/1934071970565390836)